These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17716122)

  • 21. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
    Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
    Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting.
    Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ
    J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N(6)-cyclopentyladenosine-loaded nanoparticles.
    Dalpiaz A; Vighi E; Pavan B; Leo E
    J Pharm Sci; 2009 Nov; 98(11):4272-84. PubMed ID: 19283768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
    Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
    Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
    Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
    Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
    Liu J; Qiu Z; Wang S; Zhou L; Zhang S
    Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
    Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
    Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
    Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.